In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile

Background: Clostridium difficile (C. difficile) is a major nosocomial pathogen that colonizes in the human gut. Recently, the U.S. FDA approved three new antimicrobial agents against gram-positive bacteria: Tedizolid, Dalbavancin, and Ceftobiprole. The efficacy of these antibiotics for treatment of...

Full description

Saved in:
Bibliographic Details
Published in:Front Microbiol
Main Authors: Binyamin, Dana, Nitzan, Orna, Azrad, Maya, Hamo, Zohar, Koren, Omry, Peretz, Avi
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2018
Subjects:
Microbiology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6004428/
https://ncbi.nlm.nih.gov/pubmed/29942295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2018.01256
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items